Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways

Journal of Immunology

Volumn 165, Issue 9, 2000, Pages 5227-5237

  Ahmed, S T ^a   Ivashkiv, L B ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; GAMMA INTERFERON; GLYCOPROTEIN GP 130; HYDROGEN PEROXIDE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; LIPOPOLYSACCHARIDE; SERINE; SORBITOL; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0034327736     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.9.5227     Document Type: Article

References (84)

1. Gp130 and the interleukin-6 family of cytokines
2. Cytokine expression and cell activation in inflammatory arthritis
3. Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme
4. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
5. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
6. Interleukin-11: A gp130 cytokine
7. Interleukin-11 inhibits macrophage interleukin-12 production
8. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression
9. Oncostatin M differentially regulates tissue inhibitors of metalloproteinases T1MP-1 and TIMP-3 gene expression in human synovial lining cells
10. Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts
11. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production
12. Role of IL-6 in directing the initial immune response to schistosome eggs
13. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB
14. Stimulation of hepatic acute phase response by cytokines and glucocorticoids
15. The pathophysiologic roles of interleukin-6 in human disease
16. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor
17. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
18. A new protein containing an SH2 domain that inhibits JAK kinases
19. Structure and function of a new STAT-induced STAT inhibitor
20. A family of cytokine-inducible inhibitors of signalling
21. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
22. Interleukin-6 reduces cartilage destruction during experimental arthritis: A study in interieukin-6-deficient mice
23. An anti-inflammatory role for interleukin-11 in established routine collagen-induced arthritis
24. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions
25. STATs and gene regulation
26. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice
27. Dissection of signaling cascades through gp130 in vivo: Reciprocal roles for STAT3- and SHP-2-mediated signals in immune responses
28. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
29. Protein kinase cascades in intracellular signalling by interleukin-I and tumour necrosis factor
30. Mitogen-activated protein kinase cascades as regulators of stress responses
31. Role of cytokines in rheumatoid arthritis
32. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts
33. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected Ul cells: Inhibition of inductive effects by the interleukin 1 receptor antagonist
34. Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation
35. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines
36. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation
37. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases
38. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways
39. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells
40. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes
41. Activation of monocyte effector genes and STAT family transcription factors by inflammatory synovial fluid is independent of interferon γ
42. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells
43. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion
44. Isolation of interleukin 2-induced immediate-early genes
45. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors
46. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and sarine phosphorylation
47. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and intefieukin-6
48. Interleukin-10
49. IL-10 induces the tyrosine phosphorylation of tyk2 and JakI and the differential assembly of STAT1α and STAT3 complexes in human T cells and monocytes
50. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ
51. LPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages
52. Inhibition of Stat1-mediated gene activation by PIAS1
53. Negative regulation of the JAK/STAT pathway
54. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphoryluted interleukin 3 and erythropoietin receptors
55. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
56. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
57. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation
58. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation
59. STAT3 is a serine kinase target in T lymphocytes: Interleukin 2 and T cell antigen receptor signals converge upon serine 727
60. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK)
61. Requirement for Ras/Rac 1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein
62. Disruption of the Jakl gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
63. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6
64. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors
65. The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130
66. Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner
67. Regulation of jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells
68. Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock
69. The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity
70. Serine phosphorylation of STATs
71. Differentiation-regulated serine phosphorylation of STAT1 promotes GAF activation in macrophages
72. Requirement of serine phosphorylation for formation, of STAT-promoter complexes
73. Signal transducer and activator of transcription-3 serine phosphorylation by insulin is mediated by a Ras/Raf/MEK-dependent pathway
74. Statl serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase
75. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation
76. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins
77. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons
78. Stat1 combines signals derived from IFN-γ, and LPS receptors during macrophage activation
79. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-γ, uses a different signaling pathway
80. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3
81. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
82. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
83. IgG immune complexes inhibit IFN-γ-induced transcription of the FcγRI gene in human monocytes by preventing the tyrosine phosphorylation of the p91 (Stat1) transcription factor
84. Regulation of interleukin-12 by complement receptor 3 signaling